|Bid||141.57 x 1200|
|Ask||141.90 x 800|
|Day's Range||140.49 - 143.59|
|52 Week Range||86.88 - 154.24|
|Beta (5Y Monthly)||1.27|
|PE Ratio (TTM)||60.23|
|Earnings Date||Nov 03, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||165.67|
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the launch of Find the Right Fit (FindTheRightFit-sAML.com), a U.S. patient education program developed in consultation with the Myelodysplastic Syndromes (MDS) Foundation, Inc. and the Cancer Support Community focused on empowering people affected by secondary acute myeloid leukemia (sAML) and MDS.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced its support of the American Heart Association's sleep health educational content aimed at improving the health and well-being of those struggling with healthy sleep or those living with sleep disorders. As part of the initiative, the Association, with financial support from Jazz, will create educational multimedia content that will be available at www.heart.org/en/health-topics/sleep-disorders.